PFIZER and BIONTECH announce vaccine candidate against COVID-19 achieved success in first interim analysis from phase 3 study

Contact is taking a holiday!

Contact is taking a break after 25 years of bringing you news of Tibet and Tibetan issues. We are celebrating our 25 years by bringing you the story of Contact and the people who have made it happen, and our archive is still there for you to access at any time, and below you can read the story of Contact, how it came into being and the wonderful reflections of the people who have made it happen over the years.

When and how Contact will re-emerge and evolve will be determined by those who become involved.

PFIZER and BIONTECH announce vaccine candidate against COVID-19 achieved success in first interim analysis from phase 3 study

November 11, 2020;

PFIZER | November 09, 2020 | Read the originally published press release here Vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis … Continued

The post PFIZER and BIONTECH announce vaccine candidate against COVID-19 achieved success in first interim analysis from phase 3 study appeared first on Central Tibetan Administration.